Volume Alert - MDT 68.53 Medtronic Inc $MDT Hit a high today of 68.90 Closing the day 10:30 at 68.53 -0.46 -0.67% With a day low of 68.37 and a total volume of 1,353,000.
MDT Recent Posts: http://investorshangout.com/Medtronic-Inc-MDT-51763/
MDT Medtronic Inc Recent Headline News
Midday Glance: Medical Devices companies
AP - 19 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 110.75 (-0.32), JNJ: 108.83 (-0.08), MDT: 68.58 (-0.41), BAX: 71.07 (+0.31)
Medtronic and St. Jude Medical Dominate the European Pain Management Device Market
PR Newswire - 1 hr 42 mins ago
Decision Resources Group finds that the European pain management device market generates a majority of revenue from select products, such as spinal cord stimulation (SCS) and radiofrequency (RF) ablation devices. This results in key players like Medtronic and St. Jude Medical capturing significant share. Increasing recognition of the value of pain management devices over pharmaceuticals will, however, drive moderate market growth, leading to increased competition as manufacturers shift focus to the device market.
MDT: 68.58 (-0.41)
Early Glance: Medical Devices companies
AP - 2 hrs 37 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 110.75 (-0.32), JNJ: 108.83 (-0.08), MDT: 68.58 (-0.41), BAX: 71.07 (+0.31)
Global Orthopedic Implant Physician Preference Survey 2015 - Executive Summary
M2 - Wed Nov 12, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/wkgmtc/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015 (Executive Summary)" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Key Topics Covered: - Survey Background - Survey Respondent Profile - Knee Repair Products - Foot Digit Repair Products - Hip Repair Products - Hand Digit Repair Products - Spinal Surgery Products - Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/wk...orthopedic
SNN: 33.43 (-0.48), MDT: 68.58 (-0.41), GMED: 23.11 (+0.02)
Global Orthopedic Implant Physician Preference Survey 2015
M2 - Wed Nov 12, 9:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/9rfcq6/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Survey includes: - Patient Volumes - Procedures Performed - Clinical Setting - Product prerference by manufacturer - Factors influencing produt change - Preferences by region, country and clinical setting Key Topics Covered: 1. Executive Summary 2. Research Methodology And Survey Coverage 3. Survey Respondent Profile 4. Osteoarthritis Treatment Preferences 5. Product Preference Overview 6. Knee Repair Products 7. Hip Repair Products 8. Hand Digit Repair Products 9. Foot Digit Repair Products 10. Cervical Interbody Products 11. Thoracolumbar Interbody Products 12. Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/9r...orthopedic
SNN: 33.43 (-0.48), MDT: 68.58 (-0.41), GMED: 23.11 (+0.02)
Wall Street Breakfast: Global Banks Fined $3.4B In Forex Probe
Wall Street Breakfast - Seeking Alpha - Wed Nov 12, 5:30AM CST
Economy Japanese stocks scaled seven-year highs this morning on further speculation that Prime Minister Shinzo Abe will postpone a planned sales tax hike and call a general election for December. The Sankei newspaper reported that Abe would...
VRX: 130.91 (+0.88), MDT: 68.58 (-0.41), C: 53.35 (-0.46), WMT: 79.35 (+0.34), RBS: 11.81 (-0.23), UBS: 17.33 (unch), NOK: 8.07 (-0.10), YHOO: 50.49 (+1.44), PBR: 10.63 (-0.02), SPY: 204.11 (-0.07), SAP: 66.41 (-0.91), EBAY: 54.10 (-0.09), JPM: 60.46 (-0.91), BHP: 58.02 (-0.95), AAPL: 111.04 (+1.34), BCS: 14.53 (-0.39), FRM: 6.67 (+0.13), COV: 93.00 (-0.71), HSBC: 50.18 (-0.39), FRGI: 56.07 (+0.20), ZTS: 42.92 (-0.80), DLA: 10.55 (+0.13), QQQ: 102.46 (+0.18), AOL: 46.04 (+0.81), BABA: 118.64 (+4.10)
Medtronic submits concessions for $43B Covidien takeover
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:53AM CST
MDT: 68.58 (-0.41), COV: 93.00 (-0.71)
Final Glance: Medical Devices companies
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 110.75 (-0.32), JNJ: 108.85 (-0.06), MDT: 68.58 (-0.41), BAX: 71.07 (+0.31)
Three Medtronic Infuse Personal Injury Cases Remanded to Circuit Court, Parker Waichman LLP Announces
PRWeb - Tue Nov 11, 2:30PM CST
Parker Waichman LLP, a national law firm that has long been dedicated to protecting the rights of victims who have been injured during medical procedures and by medical devices, comments on a Court ruling in which three lawsuit filed against Medtronic, Inc. will be remanded to the Circuit Court of the City of St. Louis for further proceedings. Parker Waichman LLP is collaborating on these cases with Neblett Beard & Arsneault and The Drakulich Firm.
MDT: 68.58 (-0.41)
DexCom Scales 52-Week High on Product Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 1:10PM CST
Impressive third-quarter 2014 results, recent FDA approvals for its new products along with a robust product pipeline contribute to the growth trajectory of DexCom, Inc. (DXCM), creating good momentum for 2015 as well.
ABT: 44.16 (-0.09), JNJ: 108.85 (-0.06), DXCM: 53.67 (+0.53), MDT: 68.58 (-0.41)
Mid-Term Election Impacts On The Market Revisited
Bret Jensen - at Seeking Alpha - Tue Nov 11, 10:27AM CST
SPY: 204.11 (-0.07), QQQ: 102.46 (+0.18), MDT: 68.58 (-0.41), IEF: 104.81 (+0.06), DIA: 176.08 (+0.06), STJ: 65.62 (-0.16), IWM: 117.64 (+0.27), TLT: 118.74 (+0.01)
Medtronic (MDT) Breaks Through Resistance at $69.08
Comtex SmarTrend(R) - Tue Nov 11, 10:14AM CST
Shares of Medtronic (NYSE:MDT) opened today above their pivot of $68.38 and have already reached the first level of resistance at $69.08. Should the shares continue to rise, the resistance pivots of $69.44 and $70.50 will be of interest.
MDT: 68.58 (-0.41)
Actavis Says 'Let's Make A Deal'
Bill Gunderson - Seeking Alpha - Tue Nov 11, 8:42AM CST
I wrote about generic and specialty drug company Actavis plc (NYSE: ACT ) a while back detailing the rumored love triangle between them, Allergan (NYSE: AGN ), Valeant Pharmaceuticals (NYSE: VRX ), and Salix Pharmaceuticals (NASDAQ: SLXP ). On...
DRTX: 23.93 (-0.07), AGN: 196.03 (+0.69), ACT: 241.39 (-2.24), VRX: 130.91 (+0.88), MDT: 68.58 (-0.41), SLXP: 97.34 (-1.67), SNY: 46.28 (-0.86)
Latin American Markets for Minimally Invasive Spinal Implants Executive Summary - Market is expected to reach $60.7 million by 2019
M2 - Tue Nov 11, 6:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/9zcj5t/latin_american) has announced the addition of the "Latin American Markets for Minimally Invasive Spinal Implants (Executive Summary)" report to their offering. This executive summary relates to the report 'Latin American Markets for Minimally Invasive Spinal Implants'. The Latin American minimally invasive surgery spinal implant market is expected to reach $60.7 million by 2019, driven by growth in lateral fusion procedures and increasing access to health care services in the region. The Latin American minimally invasive surgery spinal implant market includes minimally invasive interbody fusion and minimally invasive pedicle screws. Growth is expected in both segments as a result of the physiological and surgical advantages of MIS procedures. MIS interbody fusion was the most rapidly growing segment in 2012, followed by MIS pedicle screws. This report pertains to a forecast period of 10 years (2009 - 2019) for Argentina, Brazil and Mexico. Report Contents - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment & Country - Trend Analysis by Segment & Country - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback and Market Monitoring Main Segments Included: - MIS Interbody Fusion Market - MIS Pedicle Screw Market - Emerging Technologies Sub-Segments Included - Minimally Invasive Posterior Lumbar Interbody Fusion - Minimally Invasive Transforaminal Lumbar Interbody Fusion - Lateral Lumbar Interbody Fusion - Direct Lateral Interbody Fusion (DLIF?) - eXtreme Lateral Interbody Fusion (XLIF?) - Guided Lateral Interbody Fusion (GLIF) - Other Lateral Interbody Devices and Systems - Retractor MIS Pedicle Screw Market - Percutaneous MIS Pedicle Screw Market - Spinous Process Fixation - Facet Fixation - Minimally Invasive Sacroiliac Joint Fusion Companies Mentioned - Aesculap - Alphatec Spine - DePuy Synthes - Globus - K2M - LDR - Medical - Medtronic - NuVasive - Orthofix - Stryker - Zimmer For more information visit http://www.researchandmarkets.com/research/9z...n_american
MDT: 68.58 (-0.41)
U.S. Market for Peripheral Vascular Devices and Accessories Executive Summary: By 2020, the U.S. market for peripheral vascular devices will be worth over $6 billion
M2 - Tue Nov 11, 6:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/3rwwd3/u_s_market_for) has announced the addition of the "U.S. Market for Peripheral Vascular Devices and Accessories (Executive Summary)" report to their offering. The peripheral vascular device market includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion devices, stent grafts, surgical grafts, arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, catheters, guidewires, introducer sheaths, vascular closure devices and transcatheter embolization devices. These devices can be used for treating either coronary arterial or peripheral arterial disease (PAD), but only those devices used for peripheral procedures are included in this report. Older individuals and those who are obese have a higher risk of developing PAD. As result of a general increase in peripheral procedures and the development of new lower-limb treatments, the market for products such as stents and stent grafts will grow rapidly in the U.S. over the forecast period. Peripheral artery disease (PAD) remains a significantly under treated condition in the U.S and PAD is the leading cause of leg amputation. These factors will continue to drive growth in the peripheral vascular device market. In particular, the peripheral stent market is projected to grow over the forecast period. However, intense competition has led to price erosion and market penetration has moderated this once high growth segment. The launch of new technologies, including drug-eluting stents, will generate marginal revenues and only one company has sought FDA approval. In contrast, significant investments and acquisitions have taken place in the efforts of bringing the first drug-eluting balloon to the market, with Medtronic and C. R. Bard in a tight race to gain approval. Scope - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback and Market Monitoring Main Segments Included: - Peripheral Vascular Stent Market - PTA Balloon Catheter Market - Atherectomy Device Market - Chronic Total Occlusion (CTO) Device Market - Embolic Protection Device Market - Stent Graft Market - Surgical Graft Market - AV Access Thrombectomy Device Market - Inferior Vena Cava Filter Market - Diagnostic and Interventional Catheter Market - Diagnostic and Interventional Guidewire Market - Introducer Sheath Market - Vascular Closure Device Market - Transcatheter Embolization Device Market Companies Mentioned - ALN International Inc. - Abbott Laboratories - AccessClosure - AngioDynamics - AngioScore - Angiotech - Argon Medical - Arstasis - Artegraft - Asahi Intecc USA - Atrax - Atrium Medical - B. Braun - Boston Scientific - C. R. Bard - Cardiovascular Systems Inc - Cardiva CeloNova Biosciences - Cook Medical - Cordis - Covidien - Endologix - IDEV Technologies - LeMaitre Vascular - MEDRAD - Maquet - Marine Polymer Technologies - Medtronic - Morris Innovative - Penumbra - Pfizer For more information visit http://www.researchandmarkets.com/research/3r...market_for About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
BSX: 13.38 (-0.03), ABT: 44.15 (-0.10), MDT: 68.58 (-0.41), CSII: 29.25 (-0.51), LMAT: 7.01 (-0.12)
Medtronic reports November 18
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:47PM CST
MDT: 68.58 (-0.41)
Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2015
Thomson Reuters ONE - Mon Nov 10, 3:00PM CST
MINNEAPOLIS - Nov 10, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2015 on Tuesday, November 18, 2014. A news release will be issued at approximately 6:15 a.m. Central Standard Time and will be available at http://newsroom.medtronic.com. The earnings news release will include summary financial information for Medtronic's second fiscal quarter which ended October 24, 2014.
MDT: 68.58 (-0.41)
DexCom G4 Platinum Software Gains FDA Nod, Shares Surge - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 1:54PM CST
Following the announcement, shares of DexCom, Inc. (DXCM) shot up nearly 14.12% to close at $50.93 in the last trading session.
ABT: 44.15 (-0.10), JNJ: 108.85 (-0.06), DXCM: 53.67 (+0.53), MDT: 68.58 (-0.41)
MDT Recent Posts: http://investorshangout.com/Medtronic-Inc-MDT-51763/
MDT Medtronic Inc Recent Headline News
Midday Glance: Medical Devices companies
AP - 19 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 110.75 (-0.32), JNJ: 108.83 (-0.08), MDT: 68.58 (-0.41), BAX: 71.07 (+0.31)
Medtronic and St. Jude Medical Dominate the European Pain Management Device Market
PR Newswire - 1 hr 42 mins ago
Decision Resources Group finds that the European pain management device market generates a majority of revenue from select products, such as spinal cord stimulation (SCS) and radiofrequency (RF) ablation devices. This results in key players like Medtronic and St. Jude Medical capturing significant share. Increasing recognition of the value of pain management devices over pharmaceuticals will, however, drive moderate market growth, leading to increased competition as manufacturers shift focus to the device market.
MDT: 68.58 (-0.41)
Early Glance: Medical Devices companies
AP - 2 hrs 37 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 110.75 (-0.32), JNJ: 108.83 (-0.08), MDT: 68.58 (-0.41), BAX: 71.07 (+0.31)
Global Orthopedic Implant Physician Preference Survey 2015 - Executive Summary
M2 - Wed Nov 12, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/wkgmtc/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015 (Executive Summary)" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Key Topics Covered: - Survey Background - Survey Respondent Profile - Knee Repair Products - Foot Digit Repair Products - Hip Repair Products - Hand Digit Repair Products - Spinal Surgery Products - Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/wk...orthopedic
SNN: 33.43 (-0.48), MDT: 68.58 (-0.41), GMED: 23.11 (+0.02)
Global Orthopedic Implant Physician Preference Survey 2015
M2 - Wed Nov 12, 9:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/9rfcq6/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Survey includes: - Patient Volumes - Procedures Performed - Clinical Setting - Product prerference by manufacturer - Factors influencing produt change - Preferences by region, country and clinical setting Key Topics Covered: 1. Executive Summary 2. Research Methodology And Survey Coverage 3. Survey Respondent Profile 4. Osteoarthritis Treatment Preferences 5. Product Preference Overview 6. Knee Repair Products 7. Hip Repair Products 8. Hand Digit Repair Products 9. Foot Digit Repair Products 10. Cervical Interbody Products 11. Thoracolumbar Interbody Products 12. Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/9r...orthopedic
SNN: 33.43 (-0.48), MDT: 68.58 (-0.41), GMED: 23.11 (+0.02)
Wall Street Breakfast: Global Banks Fined $3.4B In Forex Probe
Wall Street Breakfast - Seeking Alpha - Wed Nov 12, 5:30AM CST
Economy Japanese stocks scaled seven-year highs this morning on further speculation that Prime Minister Shinzo Abe will postpone a planned sales tax hike and call a general election for December. The Sankei newspaper reported that Abe would...
VRX: 130.91 (+0.88), MDT: 68.58 (-0.41), C: 53.35 (-0.46), WMT: 79.35 (+0.34), RBS: 11.81 (-0.23), UBS: 17.33 (unch), NOK: 8.07 (-0.10), YHOO: 50.49 (+1.44), PBR: 10.63 (-0.02), SPY: 204.11 (-0.07), SAP: 66.41 (-0.91), EBAY: 54.10 (-0.09), JPM: 60.46 (-0.91), BHP: 58.02 (-0.95), AAPL: 111.04 (+1.34), BCS: 14.53 (-0.39), FRM: 6.67 (+0.13), COV: 93.00 (-0.71), HSBC: 50.18 (-0.39), FRGI: 56.07 (+0.20), ZTS: 42.92 (-0.80), DLA: 10.55 (+0.13), QQQ: 102.46 (+0.18), AOL: 46.04 (+0.81), BABA: 118.64 (+4.10)
Medtronic submits concessions for $43B Covidien takeover
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:53AM CST
MDT: 68.58 (-0.41), COV: 93.00 (-0.71)
Final Glance: Medical Devices companies
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 110.75 (-0.32), JNJ: 108.85 (-0.06), MDT: 68.58 (-0.41), BAX: 71.07 (+0.31)
Three Medtronic Infuse Personal Injury Cases Remanded to Circuit Court, Parker Waichman LLP Announces
PRWeb - Tue Nov 11, 2:30PM CST
Parker Waichman LLP, a national law firm that has long been dedicated to protecting the rights of victims who have been injured during medical procedures and by medical devices, comments on a Court ruling in which three lawsuit filed against Medtronic, Inc. will be remanded to the Circuit Court of the City of St. Louis for further proceedings. Parker Waichman LLP is collaborating on these cases with Neblett Beard & Arsneault and The Drakulich Firm.
MDT: 68.58 (-0.41)
DexCom Scales 52-Week High on Product Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 1:10PM CST
Impressive third-quarter 2014 results, recent FDA approvals for its new products along with a robust product pipeline contribute to the growth trajectory of DexCom, Inc. (DXCM), creating good momentum for 2015 as well.
ABT: 44.16 (-0.09), JNJ: 108.85 (-0.06), DXCM: 53.67 (+0.53), MDT: 68.58 (-0.41)
Mid-Term Election Impacts On The Market Revisited
Bret Jensen - at Seeking Alpha - Tue Nov 11, 10:27AM CST
SPY: 204.11 (-0.07), QQQ: 102.46 (+0.18), MDT: 68.58 (-0.41), IEF: 104.81 (+0.06), DIA: 176.08 (+0.06), STJ: 65.62 (-0.16), IWM: 117.64 (+0.27), TLT: 118.74 (+0.01)
Medtronic (MDT) Breaks Through Resistance at $69.08
Comtex SmarTrend(R) - Tue Nov 11, 10:14AM CST
Shares of Medtronic (NYSE:MDT) opened today above their pivot of $68.38 and have already reached the first level of resistance at $69.08. Should the shares continue to rise, the resistance pivots of $69.44 and $70.50 will be of interest.
MDT: 68.58 (-0.41)
Actavis Says 'Let's Make A Deal'
Bill Gunderson - Seeking Alpha - Tue Nov 11, 8:42AM CST
I wrote about generic and specialty drug company Actavis plc (NYSE: ACT ) a while back detailing the rumored love triangle between them, Allergan (NYSE: AGN ), Valeant Pharmaceuticals (NYSE: VRX ), and Salix Pharmaceuticals (NASDAQ: SLXP ). On...
DRTX: 23.93 (-0.07), AGN: 196.03 (+0.69), ACT: 241.39 (-2.24), VRX: 130.91 (+0.88), MDT: 68.58 (-0.41), SLXP: 97.34 (-1.67), SNY: 46.28 (-0.86)
Latin American Markets for Minimally Invasive Spinal Implants Executive Summary - Market is expected to reach $60.7 million by 2019
M2 - Tue Nov 11, 6:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/9zcj5t/latin_american) has announced the addition of the "Latin American Markets for Minimally Invasive Spinal Implants (Executive Summary)" report to their offering. This executive summary relates to the report 'Latin American Markets for Minimally Invasive Spinal Implants'. The Latin American minimally invasive surgery spinal implant market is expected to reach $60.7 million by 2019, driven by growth in lateral fusion procedures and increasing access to health care services in the region. The Latin American minimally invasive surgery spinal implant market includes minimally invasive interbody fusion and minimally invasive pedicle screws. Growth is expected in both segments as a result of the physiological and surgical advantages of MIS procedures. MIS interbody fusion was the most rapidly growing segment in 2012, followed by MIS pedicle screws. This report pertains to a forecast period of 10 years (2009 - 2019) for Argentina, Brazil and Mexico. Report Contents - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment & Country - Trend Analysis by Segment & Country - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback and Market Monitoring Main Segments Included: - MIS Interbody Fusion Market - MIS Pedicle Screw Market - Emerging Technologies Sub-Segments Included - Minimally Invasive Posterior Lumbar Interbody Fusion - Minimally Invasive Transforaminal Lumbar Interbody Fusion - Lateral Lumbar Interbody Fusion - Direct Lateral Interbody Fusion (DLIF?) - eXtreme Lateral Interbody Fusion (XLIF?) - Guided Lateral Interbody Fusion (GLIF) - Other Lateral Interbody Devices and Systems - Retractor MIS Pedicle Screw Market - Percutaneous MIS Pedicle Screw Market - Spinous Process Fixation - Facet Fixation - Minimally Invasive Sacroiliac Joint Fusion Companies Mentioned - Aesculap - Alphatec Spine - DePuy Synthes - Globus - K2M - LDR - Medical - Medtronic - NuVasive - Orthofix - Stryker - Zimmer For more information visit http://www.researchandmarkets.com/research/9z...n_american
MDT: 68.58 (-0.41)
U.S. Market for Peripheral Vascular Devices and Accessories Executive Summary: By 2020, the U.S. market for peripheral vascular devices will be worth over $6 billion
M2 - Tue Nov 11, 6:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/3rwwd3/u_s_market_for) has announced the addition of the "U.S. Market for Peripheral Vascular Devices and Accessories (Executive Summary)" report to their offering. The peripheral vascular device market includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion devices, stent grafts, surgical grafts, arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, catheters, guidewires, introducer sheaths, vascular closure devices and transcatheter embolization devices. These devices can be used for treating either coronary arterial or peripheral arterial disease (PAD), but only those devices used for peripheral procedures are included in this report. Older individuals and those who are obese have a higher risk of developing PAD. As result of a general increase in peripheral procedures and the development of new lower-limb treatments, the market for products such as stents and stent grafts will grow rapidly in the U.S. over the forecast period. Peripheral artery disease (PAD) remains a significantly under treated condition in the U.S and PAD is the leading cause of leg amputation. These factors will continue to drive growth in the peripheral vascular device market. In particular, the peripheral stent market is projected to grow over the forecast period. However, intense competition has led to price erosion and market penetration has moderated this once high growth segment. The launch of new technologies, including drug-eluting stents, will generate marginal revenues and only one company has sought FDA approval. In contrast, significant investments and acquisitions have taken place in the efforts of bringing the first drug-eluting balloon to the market, with Medtronic and C. R. Bard in a tight race to gain approval. Scope - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback and Market Monitoring Main Segments Included: - Peripheral Vascular Stent Market - PTA Balloon Catheter Market - Atherectomy Device Market - Chronic Total Occlusion (CTO) Device Market - Embolic Protection Device Market - Stent Graft Market - Surgical Graft Market - AV Access Thrombectomy Device Market - Inferior Vena Cava Filter Market - Diagnostic and Interventional Catheter Market - Diagnostic and Interventional Guidewire Market - Introducer Sheath Market - Vascular Closure Device Market - Transcatheter Embolization Device Market Companies Mentioned - ALN International Inc. - Abbott Laboratories - AccessClosure - AngioDynamics - AngioScore - Angiotech - Argon Medical - Arstasis - Artegraft - Asahi Intecc USA - Atrax - Atrium Medical - B. Braun - Boston Scientific - C. R. Bard - Cardiovascular Systems Inc - Cardiva CeloNova Biosciences - Cook Medical - Cordis - Covidien - Endologix - IDEV Technologies - LeMaitre Vascular - MEDRAD - Maquet - Marine Polymer Technologies - Medtronic - Morris Innovative - Penumbra - Pfizer For more information visit http://www.researchandmarkets.com/research/3r...market_for About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
BSX: 13.38 (-0.03), ABT: 44.15 (-0.10), MDT: 68.58 (-0.41), CSII: 29.25 (-0.51), LMAT: 7.01 (-0.12)
Medtronic reports November 18
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:47PM CST
MDT: 68.58 (-0.41)
Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2015
Thomson Reuters ONE - Mon Nov 10, 3:00PM CST
MINNEAPOLIS - Nov 10, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2015 on Tuesday, November 18, 2014. A news release will be issued at approximately 6:15 a.m. Central Standard Time and will be available at http://newsroom.medtronic.com. The earnings news release will include summary financial information for Medtronic's second fiscal quarter which ended October 24, 2014.
MDT: 68.58 (-0.41)
DexCom G4 Platinum Software Gains FDA Nod, Shares Surge - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 1:54PM CST
Following the announcement, shares of DexCom, Inc. (DXCM) shot up nearly 14.12% to close at $50.93 in the last trading session.
ABT: 44.15 (-0.10), JNJ: 108.85 (-0.06), DXCM: 53.67 (+0.53), MDT: 68.58 (-0.41)
